C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
12/2004
12/09/2004	CA2527136A1 Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds
12/09/2004	CA2526712A1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
12/09/2004	CA2526530A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
12/08/2004	EP1483280A2 Fluorescent nitrogenous base and nucleosides incorporating same
12/08/2004	EP1483265A1 Purine derivatives as kinase inhibitors
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483256A2 Process for making chiral 1,4-disubstituted piperazines
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1149102B1 Triazolo-pyridazine derivatives as ligands for gaba receptors
12/08/2004	EP1061076B1 N-acyl cyclic amine derivatives
12/08/2004	EP0972775B1 Pyrroloindole derivatives and intermediates in producing the same
12/08/2004	EP0831094B1 Fused polycyclic heterocycle derivatives
12/08/2004	CN1553938A 荧光二酮吡咯并吡咯 Fluorescent diketopyrrolopyrrole
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553914A Process for the preparation of highly pure triethylene diamine
12/08/2004	CN1553913A Process for the direct preparation of pyrrolo [3,4-c]pyrroles
12/08/2004	CN1553912A Process for the preparation of diketopyrrolopyrroles
12/08/2004	CN1553911A Pyrrole derivatives, their preparation and their therapeutic uses
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553814A Remedies for arteriosclerosis
12/08/2004	CN1552714A 2-substituted benzyl-5,7-dihydrocarbyl-3,7-dihydro pyrroline [2,3-d] pyromidine-4-one derivative ,its preparation and medicinal use
12/08/2004	CN1552713A Peimequizane salt and its preparation
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178938C 1,2-annelated quinoline derivatives
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828326 Pyrimidinone fused bicyclic metalloproteinase inhibitors
12/07/2004	US6828322 Triazolo-pyridazine derivatives as ligands for GABA receptors
12/07/2004	US6828316 Antiallergens
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828314 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/07/2004	US6828159 Carbopyronine fluorescent dyes
12/07/2004	US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect
12/07/2004	CA2272136C Pyrazole derivatives having crf antagonist activity
12/07/2004	CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/02/2004	WO2004104008A1 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR INTERMEDIATES
12/02/2004	WO2004104007A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
12/02/2004	WO2004104006A2 PROCESS FOR SYNTHESIZING β-LACTAMASE INHIBITOR IN INTERMEDIATES
12/02/2004	WO2004104003A1 Novel pyridopyrazines and use thereof as kinase modulators
12/02/2004	WO2004104002A1 Novel pyridopyrazines and use thereof as kinase inhibitors
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103958A2 Preparation of hymenialdisine derivatives and use thereof
12/02/2004	WO2004103276A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/02/2004	WO2004094431A3 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
12/02/2004	US20040242894 Novel synthesis of 2-butyl-3-(2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one
12/02/2004	US20040242874 Process for synthesizing beta-lactamase inhibitor intermediates
12/02/2004	US20040242867 Photoinitiators; basic catalyst; absorption of light
12/02/2004	US20040242648 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
12/02/2004	US20040242644 Nicotinic acetylcholine receptors to treat pain
12/02/2004	US20040242641 Nicotinic acetylcholine receptors to treat pain
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242605 Medicine containing pyrimidine derivative
12/02/2004	US20040242600 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur
12/02/2004	US20040242596 such as N-(3-Amino-propyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-propyl]-4-chloro-benzamide; for interrupting mitosis; antiproliferatives and anticancer agents
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242587 Pyrrolo[1,2-b]pyridazine compounds
12/02/2004	US20040242586 gamma-aminobutyric acid receptor ligands, prepared by reacting [2-(2-(trimethylsilanyl)ethoxymethyl)-2H-[1,2,4]triazol-3-yl]methanol and 7-tert-butyl-6-chloro-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine, then deprotecting, to form drugs used as anticonvulsants and anxiolytic agents
12/02/2004	US20040242583 to prevent and treat diabetes type 1 and type 2; reduce blood sugar levels; inhibit phosphotyrosine phosphatase
12/02/2004	US20040242580 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants
12/02/2004	US20040242577 N-methyl 2-morpholine-4-carbonyl or sulfonyl substituted; for example: 2-{[4-(3,4-dichlorophenoxy)piperidin-1-yl]methyl}morpholine; useful for treating asthma and/or rhinitis
12/02/2004	US20040242573 Novel compounds
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242498 CXCR3 antagonists
12/02/2004	US20040237915 Roller tappet with cold advance
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2525507A1 Process for synthesizing .beta.-lactamase inhibitor intermediates
12/02/2004	CA2525504A1 Process for synthesizing .beta.-lactamase inhibitor in intermediates
12/02/2004	CA2524948A1 Novel pyridopyrazines and use thereof as kinase inhibitors
12/02/2004	CA2524531A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/01/2004	EP1481977A1 Nitrogen-containing heterocyclic compound
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1480983A1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
12/01/2004	EP1480981A1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
12/01/2004	EP1480977A2 Substituted aryl compounds for treatment of disease
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480958A1 Uracil-thioether
12/01/2004	EP1480644A2 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
12/01/2004	EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004	EP1399448B1 Imidazo 1,5-a] pyrimido 5,4-d] benzazepine derivatives as gaba a receptor modulators
12/01/2004	EP1368352B1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/01/2004	EP1263761B1 Compounds for pdt
12/01/2004	EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004	EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004	EP1117666B1 Process for the preparation of corroles and several such new compounds, including chiral derivatives, and the use thereof
12/01/2004	CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
12/01/2004	CN1551881A Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
12/01/2004	CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825373 Reacting an aminopyrrol derivative with and isothiocyanatoformic acid ester derivative to form an adduct,cyclizing the adduct to form pyrrolotriazin-4-one derivative
11/30/2004	US6825347 Uronium and immonium salts for peptide coupling

1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 573